The change is driven by new international pricing rules in the United States, which are having a ripple effect on medicine costs worldwide - impacting all suppliers of Mounjaro.
Our supplier Lilly is raising the UK price for all providers from Monday, September 1st.

We do not yet know what our new selling prices will be, or from what date they’ll increase. We will share this openly and clearly as soon as we know.

No, we are not currently taking new orders for Mounjaro. 
To protect supply and keep costs lower for longer, we are prioritising our existing Mounjaro patients only.

You’ll need to take a short, one-week break (called a “washout period”) after stopping Mounjaro before you can start using Wegovy.
This advice is the same no matter what dosage of Mounjaro you’re currently taking.

Do I need to restart from the lowest dose?
There are no studies from Novo Nordisk evaluating the conversion dose from Mounjaro to Wegovy, therefore the impact on potential adverse events and weight are unknown and clinical judgment should be exercised.
Our clinical team will help you find the Wegovy dose that best suits you. We’ll base this on your current Mounjaro dosage, how well you tolerate the medication and your results so far.

Do I need to book an appointment to switch?
Yes, you will need to book a consultation with one of our GPs. New customers that request to switch to Wegovy will require proof of existing prescription to start above the initial dose.

The decision balances long-term cost vs weight loss results.

Our number one priority is helping you continue your weight loss jouney with a little disruption as possible.

We’re only recommending a switch if Mounjaro’s new price makes it difficult for you to continue treatment. If it’s still viable for you and you’re doing well on it, we’d encourage you to stay on your current plan.

For those who need a more cost-effective option, Wegovy offers similar weight-loss results and some additional benefits, including support for heart health. If you choose to switch, our clinicians will make sure the change is safe, smooth, and tailored to you. That way, you can keep moving towards your health goals with minimal disruption.

The main difference is their active ingredients. Wegovy uses semaglutide (a GLP-1 agonist), while Mounjaro uses tirzepatide (a dual GIP and GLP-1 agonist). This can lead to different average weight loss results and side effects.

Studies indicate that Mounjaro may be slightly more effective than Wegovy. Those using Mounjaro lost an average of 22.5% of their starting body weight after 72 weeks. While those using Wegovy lost an average of 15% of their starting weight after 68 weeks. However, Wegovy may get to work slightly faster.